Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent-Reference-Cited by-同舟云学术

Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent

Published:2020-12 Issue: Volume:42 Page:101087
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Azar Shahar,Udi Shiran,Drori Adi,Hadar Rivka,Nemirovski Alina,Vemuri Kiran V.,Miller Maya,Sherill-Rofe Dana,Arad Yhara,Gur-Wahnon Devorah,Li Xiaoling,Makriyannis Alexandros,Ben-Zvi Danny,Tabach Yuval,Ben-Dov Iddo Z.,Tam Joseph^ORCID

Funder

Israel Science Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference97 articles.

1. Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease;Adinolfi;Hepatobiliary Surgery and Nutrition,2018

2. Endocannabinoids in liver disease;Tam;Hepatology,2011

3. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity;Osei-Hyiaman;Journal of Clinical Investigation,2005

4. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice;Osei-Hyiaman;Journal of Clinical Investigation,2008

5. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice;Liu;Gastroenterology,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Modulation of p53 and p21 Genes Expression in Cardiovascular Cultured Cells;Academia Open;2024-06-13

3. Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner;Cardiovascular Research;2024-06-05

4. The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target;PeerJ;2024-03-29

5. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway;Journal of Translational Medicine;2024-03-26